Larvol Delta - ADMA-Biologics-Announces-Closing-of-5175-Million-Public-Offering-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares

Bivigam (immune globulin intravenous [human]) - ADMA Biologics

http://www.globenewswire.com/news-release/2019/05/21/1840421/0/en/ADMA-Biologics-Announces-Closing-of-51-75-Million-Public-Offering-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html

May 21, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next